Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?

類似資料

• Plasma nuclear matrix protein (NMP) levels in patients with multiple organ failure
  著者:: Endo, S, 等
  出版事項: (1997)
• Usefulness of the NMP22BladderChek Test for Screening and Follow-up of Bladder Cancer
  著者:: Choi, Hwa Sub, 等
  出版事項: (2010)
• Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22
  著者:: Kelly, John D., 等
  出版事項: (2012)
• Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis
  著者:: Liang, Qindong, 等
  出版事項: (2018)
• The nuclear matrix protein NMP-1 is the transcription factor YY1.
  著者:: Guo, B, 等
  出版事項: (1995)